Out Now: 2 Stocks to Ride India's EV Megatrend
Here is the latest financial fact sheet of BROOKS LAB. For more details, see the BROOKS LAB quarterly results and BROOKS LAB share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -3.7 |
No. of shares | m | 24.70 |
1 Week | % | 4.2 |
1 Month | % | -1.4 |
1 Year | % | -27.8 |
52 week H/L | Rs | 141.8/57.1 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
BROOKS LAB EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 153 | 123 | 63 | 78 | 155 | |
Low | Rs | 79 | 38 | 14 | 16 | 60 | |
Sales per share (Unadj.) | Rs | 33.7 | 34.0 | 28.2 | 31.3 | 36.9 | |
Earnings per share (Unadj.) | Rs | -8.5 | -9.1 | -9.9 | -7.8 | -7.8 | |
Diluted earnings per share | Rs | -5.6 | -6.0 | -9.9 | -7.8 | -7.8 | |
Cash flow per share (Unadj.) | Rs | -4.6 | -5.1 | -7.2 | -5.0 | -4.8 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 70.7 | 61.5 | 39.8 | 32.0 | 25.5 | |
Adj. book value per share | Rs | 46.3 | 40.3 | 39.8 | 32.0 | 25.5 | |
Shares outstanding (eoy) | m | 16.19 | 16.19 | 24.70 | 24.70 | 24.70 | |
Price / Sales ratio | x | 3.4 | 2.4 | 1.4 | 1.5 | 2.9 | |
Avg P/E ratio | x | -13.6 | -8.8 | -3.9 | -6.0 | -13.7 | |
P/CF ratio (eoy) | x | -25.4 | -15.7 | -5.4 | -9.5 | -22.2 | |
Price / Book Value ratio | x | 1.6 | 1.3 | 1.0 | 1.5 | 4.2 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 1,874 | 1,302 | 957 | 1,157 | 2,654 | |
Total wages/salary | Rs m | 97 | 100 | 112 | 120 | 169 |
BROOKS LAB INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 545 | 550 | 697 | 772 | 911 | |
Other income | Rs m | 2 | 29 | 4 | 7 | 9 | |
Total revenues | Rs m | 548 | 579 | 701 | 780 | 920 | |
Gross profit | Rs m | -89 | -84 | -39 | 5 | -144 | |
Depreciation | Rs m | 64 | 65 | 66 | 71 | 74 | |
Interest | Rs m | 24 | 30 | 34 | 31 | 31 | |
Profit before tax | Rs m | -175 | -149 | -135 | -90 | -239 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -37 | -1 | 109 | 104 | -46 | |
Profit after tax | Rs m | -138 | -148 | -244 | -194 | -193 | |
Gross profit margin | % | -16.4 | -15.2 | -5.6 | 0.7 | -15.8 | |
Effective tax rate | % | 21.2 | 1.0 | -80.4 | -115.4 | 19.2 | |
Net profit margin | % | -25.3 | -26.9 | -35.0 | -25.1 | -21.2 |
BROOKS LAB BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 307 | 317 | 379 | 474 | 612 | |
Current liabilities | Rs m | 405 | 474 | 458 | 636 | 489 | |
Net working cap to sales | % | -17.9 | -28.4 | -11.3 | -21.0 | 13.5 | |
Current ratio | x | 0.8 | 0.7 | 0.8 | 0.7 | 1.3 | |
Inventory Days | Days | 45 | 51 | 36 | 18 | 33 | |
Debtors Days | Days | 682 | 757 | 815 | 647 | 708 | |
Net fixed assets | Rs m | 1,312 | 1,252 | 1,199 | 1,122 | 1,334 | |
Share capital | Rs m | 162 | 162 | 247 | 247 | 247 | |
"Free" reserves | Rs m | 983 | 834 | 737 | 544 | 383 | |
Net worth | Rs m | 1,145 | 996 | 984 | 791 | 631 | |
Long term debt | Rs m | 166 | 139 | 114 | 144 | 93 | |
Total assets | Rs m | 1,619 | 1,570 | 1,579 | 1,621 | 1,946 | |
Interest coverage | x | -6.3 | -4.0 | -3.0 | -1.9 | -6.7 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | |
Sales to assets ratio | x | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | |
Return on assets | % | -7.0 | -7.5 | -13.3 | -10.0 | -8.3 | |
Return on equity | % | -12.1 | -14.9 | -24.8 | -24.5 | -30.6 | |
Return on capital | % | -11.5 | -10.6 | -9.3 | -6.3 | -28.8 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
BROOKS LAB CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -62 | -50 | -94 | 45 | -374 | |
From Investments | Rs m | -51 | 11 | -23 | -51 | -249 | |
From Financial Activity | Rs m | 118 | 58 | 96 | 12 | 641 | |
Net Cashflow | Rs m | 5 | 19 | -21 | 5 | 17 |
Share Holding
Shareholding as on Mar 2023
|
Company Information
|
CHM: Atul Ranchal | COMP SEC: Jai Vaidya | YEAR OF INC: 2002 | BSE CODE: 533543 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA PIRAMAL ENTERPRISES SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
Compare BROOKS LAB With: AUROBINDO PHARMA PIRAMAL ENTERPRISES SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
After opening the day flat, Indian share markets declined for the second straight session on Friday.